IL162432A0 - Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compounds - Google Patents
Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compoundsInfo
- Publication number
- IL162432A0 IL162432A0 IL16243202A IL16243202A IL162432A0 IL 162432 A0 IL162432 A0 IL 162432A0 IL 16243202 A IL16243202 A IL 16243202A IL 16243202 A IL16243202 A IL 16243202A IL 162432 A0 IL162432 A0 IL 162432A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrazolylbenzylsulfonamidesand
- medicaments
- compounds
- deuterated substituted
- deuterated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10162121A DE10162121A1 (de) | 2001-12-12 | 2001-12-12 | Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel |
PCT/DE2002/004600 WO2003050091A1 (de) | 2001-12-12 | 2002-12-11 | Deuterierte substituierte pyrazolyl-benzolsulfonamide sowie diese verbindungen enthaltende arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162432A0 true IL162432A0 (en) | 2005-11-20 |
Family
ID=7709640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16243202A IL162432A0 (en) | 2001-12-12 | 2002-12-11 | Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compounds |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050222238A1 (xx) |
EP (1) | EP1456179A1 (xx) |
JP (1) | JP2005516009A (xx) |
CN (1) | CN1612863A (xx) |
AU (1) | AU2002357973A1 (xx) |
CA (1) | CA2471743A1 (xx) |
DE (1) | DE10162121A1 (xx) |
HU (1) | HUP0402422A2 (xx) |
IL (1) | IL162432A0 (xx) |
IS (1) | IS7304A (xx) |
NO (1) | NO20042906L (xx) |
PL (1) | PL370563A1 (xx) |
RU (1) | RU2004121033A (xx) |
WO (1) | WO2003050091A1 (xx) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101268050B (zh) * | 2005-07-26 | 2012-11-28 | 奈科明有限责任公司 | 同位素取代的泮托拉唑 |
US7601737B2 (en) * | 2005-07-26 | 2009-10-13 | Nycomed Gmbh | Isotopically substituted proton pump inhibitors |
CN101268051B (zh) * | 2005-07-26 | 2011-08-31 | 奈科明有限责任公司 | 同位素取代的质子泵抑制剂 |
EP1934201A1 (en) * | 2005-10-06 | 2008-06-25 | Auspex Pharmaceuticals Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
US20070287734A1 (en) * | 2006-06-09 | 2007-12-13 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity |
WO2008070619A1 (en) * | 2006-12-04 | 2008-06-12 | Auspex Pharmaceuticals, Inc. | Deuterated oxazolidinones and their use as antibiotics |
JP2010512343A (ja) * | 2006-12-08 | 2010-04-22 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 置換アリルアミン類の調製および実用性 |
US20080299216A1 (en) * | 2007-06-01 | 2008-12-04 | Protia, Llc | Deuterium-enriched aripiprazole |
US20090062364A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched celecoxib |
US20090062185A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched anidulafungin |
US20090209608A1 (en) * | 2007-08-29 | 2009-08-20 | Protia, Llc | Deuterium-enriched asenapine |
US20090069219A1 (en) * | 2007-09-09 | 2009-03-12 | Protia, Llc | Deuterium-enriched telavancin |
US20090076158A1 (en) * | 2007-09-13 | 2009-03-19 | Protia, Llc | Deuterium-enriched bicalutamide |
US20090075870A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched caspofungin |
US20090082419A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched tegaserod |
US20100120756A1 (en) * | 2008-09-17 | 2010-05-13 | Auspex Pharmaceuticals, Inc. | Phenothiazine modulators of h1 receptors |
US8227451B2 (en) * | 2008-11-12 | 2012-07-24 | Auspex Pharmaceuticals | Phenylacetic acid inhibitors of cyclooxygenase |
AR075584A1 (es) | 2009-02-27 | 2011-04-20 | Intermune Inc | COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO. |
US20120244122A1 (en) * | 2009-05-28 | 2012-09-27 | Masse Craig E | Peptides for the Treatment of HCV Infections |
CN102712644A (zh) * | 2009-09-28 | 2012-10-03 | 豪夫迈·罗氏有限公司 | 丙肝病毒复制的新型大环抑制剂 |
US20150031768A1 (en) * | 2011-08-19 | 2015-01-29 | The Trustees Of Princeton University | C-halogen bond formation |
KR20230023817A (ko) | 2013-12-03 | 2023-02-17 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
CN106535898A (zh) * | 2014-04-04 | 2017-03-22 | 细胞内治疗公司 | 有机化合物 |
EP3407889B1 (en) | 2016-03-25 | 2021-05-19 | Intra-Cellular Therapies, Inc. | Organic compounds and their use in treating or preventing central nervous system disorders |
JP7013454B2 (ja) | 2016-10-12 | 2022-02-15 | イントラ-セルラー・セラピーズ・インコーポレイテッド | アモルファス固体分散体 |
CN116327770A (zh) | 2017-03-24 | 2023-06-27 | 细胞内治疗公司 | 新组合物和方法 |
JP7457000B2 (ja) | 2018-08-31 | 2024-03-27 | イントラ-セルラー・セラピーズ・インコーポレイテッド | 新規方法 |
KR20210052471A (ko) | 2018-08-31 | 2021-05-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10075033I2 (de) * | 1993-11-30 | 2001-08-02 | Searle & Co | substituierte Pyrazolyl-benzolsulfonamide zur Behandlung von Entzündungen. |
US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
EP1104760B1 (en) * | 1999-12-03 | 2003-03-12 | Pfizer Products Inc. | Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
-
2001
- 2001-12-12 DE DE10162121A patent/DE10162121A1/de not_active Withdrawn
-
2002
- 2002-12-11 CA CA002471743A patent/CA2471743A1/en not_active Abandoned
- 2002-12-11 WO PCT/DE2002/004600 patent/WO2003050091A1/de not_active Application Discontinuation
- 2002-12-11 AU AU2002357973A patent/AU2002357973A1/en not_active Abandoned
- 2002-12-11 JP JP2003551116A patent/JP2005516009A/ja active Pending
- 2002-12-11 US US10/498,708 patent/US20050222238A1/en not_active Abandoned
- 2002-12-11 EP EP02791628A patent/EP1456179A1/de not_active Withdrawn
- 2002-12-11 IL IL16243202A patent/IL162432A0/xx unknown
- 2002-12-11 RU RU2004121033/04A patent/RU2004121033A/ru not_active Application Discontinuation
- 2002-12-11 CN CNA028268423A patent/CN1612863A/zh active Pending
- 2002-12-11 PL PL02370563A patent/PL370563A1/xx not_active Application Discontinuation
- 2002-12-11 HU HU0402422A patent/HUP0402422A2/hu unknown
-
2004
- 2004-06-10 IS IS7304A patent/IS7304A/is unknown
- 2004-07-09 NO NO20042906A patent/NO20042906L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL370563A1 (en) | 2005-05-30 |
IS7304A (is) | 2004-06-10 |
EP1456179A1 (de) | 2004-09-15 |
AU2002357973A1 (en) | 2003-06-23 |
CN1612863A (zh) | 2005-05-04 |
NO20042906L (no) | 2004-07-09 |
DE10162121A1 (de) | 2003-06-18 |
US20050222238A1 (en) | 2005-10-06 |
WO2003050091A1 (de) | 2003-06-19 |
CA2471743A1 (en) | 2003-06-19 |
RU2004121033A (ru) | 2006-01-10 |
JP2005516009A (ja) | 2005-06-02 |
HUP0402422A2 (hu) | 2005-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL162432A0 (en) | Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compounds | |
GB0112834D0 (en) | Medicaments | |
AU2002365120A8 (en) | Medicaments | |
IL162406A0 (en) | Deuterated substituted dihydrofuranones and medicaments containing these compounds | |
GB0101225D0 (en) | Pharmaceutical compounds | |
GB0101227D0 (en) | Pharmaceutical compounds | |
GB0128415D0 (en) | Medicaments | |
GB0102902D0 (en) | Medicaments | |
GB0105469D0 (en) | Medicaments | |
AU2002342940A8 (en) | New pharmaceutical compounds | |
HUP0402343A3 (en) | Substituted beta-aminoalcohols used as medicaments | |
GB0115182D0 (en) | Medicaments | |
GB0126997D0 (en) | Medicinal Compounds | |
GB0127024D0 (en) | Medicinal compounds | |
GB0122201D0 (en) | Medicinal compounds | |
GB0105741D0 (en) | Medicinal compounds | |
GB0105740D0 (en) | Medicinal compounds | |
GB0125057D0 (en) | Medicaments | |
GB0106875D0 (en) | Medicaments | |
GB0125233D0 (en) | Medicaments | |
GB0125056D0 (en) | Medicaments | |
GB0124551D0 (en) | Medicaments | |
GB0124538D0 (en) | Medicaments | |
GB0124537D0 (en) | Medicaments | |
GB0124161D0 (en) | Medicaments |